Vvardis Plans New York IPO at Valuation of Up to $4.4 Billion Despite Losses

Swiss dental company Vvardis plans to list in New York, targeting a valuation of up to $4.4 billion. Founders Haley and Goly Abivardi’s company is reporting losses and debt.